← All trials
NCT04530396
Phase 3Interventional
Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 7, 2020
- Primary completion
- May 1, 2021
- Completion date
- May 1, 2021
- First posted
- Aug 28, 2020
- Last posted
- Oct 27, 2020
- Enrollment
- 40000
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Government of RussiaLead sponsor
- Crocus Medical BVCollaborator
- Government of RussiaCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.